RESEARCH DOSSIER
Functional Neurological Disorder: Multidisciplinary Rehabilitation
Abstract. This monograph examines multidisciplinary rehabilitation for functional neurological disorder (FND) through historical, conceptual, clinical, and empirical research. It assesses diagnosis explanation, predictive-processing accounts, motor retraining, occupational performance, speech and communication, psychological interventions, functional seizures, comorbidity, pediatric rehabilitation, patient agency, service implementation, and outcome measurement. The evidence includes expert consensus, feasibility studies, randomized trials, patient-experience research, and a 2026 rehabilitation meta-analysis. The synthesis distinguishes change within treatment groups from comparative efficacy, preserving the primary negative findings of Physio4FMD and CODES alongside their secondary outcomes and the favorable but heterogeneous signals across rehabilitation trials. It concludes that multidisciplinary practice is a coherent clinical approach whose effects must be evaluated by phenotype, intervention, comparator, outcome, and setting.
Keywords: functional neurological disorder; FND; functional motor disorder; multidisciplinary rehabilitation; specialist physiotherapy; occupational therapy; functional seizures; cognitive behavioral therapy; neurorehabilitation; agency; ICF; clinical trials; participation.
Scientific Overview and Scope
Functional neurological disorder (FND) describes neurological symptoms associated with altered functioning of nervous-system networks that govern movement, sensation, episodes of altered awareness, speech, and related functions. Its clinical recognition rests on characteristic positive features of the presentation, interpreted in an appropriate medical context. A rehabilitation-centered account examines how symptoms interact with activity, participation, attention, expectations, physical conditioning, emotional processes, and social environments. The relevant question is how a person can acquire or recover useful capacities while living with symptoms that can be severe, variable, and disabling.
This monograph investigates multidisciplinary rehabilitation of FND as a specific research object. It synthesizes the clinical literature on explanation of diagnosis, movement retraining, occupational performance, communication rehabilitation, psychological treatment, coordinated care, family involvement, outcome measurement, service delivery, and long-term functioning. It covers functional motor disorder most extensively because it has the strongest specialist physiotherapy trial literature, while distinguishing functional seizures and other symptom phenotypes whose intervention evidence follows different trajectories. The clinical foundations are informed by Espay et al. (2018) (https://doi.org/10.1001/jamaneurol.2018.1264), and the functional outcome framework by the World Health Organization's ICF (https://www.who.int/standards/classifications/international-classification-of-functioning-disability-and-health). Source 3 Source 16
The study is a critical narrative research synthesis, based on a purposive selection of identifiable primary trials, expert consensus statements, peer-reviewed syntheses, and official classification material available for inspection by November 2, 2026. It does not claim a PRISMA search, exhaustive systematic review, quantitative reanalysis, new patient-level data, or an independently obtained clinical examination. Where only an article's abstract or publisher summary could be consulted, interpretation is confined to the information contained there. Its conclusions concern the state and limits of scientific evidence, not individual treatment prescriptions.
Conceptual Identity of FND Rehabilitation
The defining object of rehabilitation is the person's capacity to perform activities, exercise agency, sustain valued roles, and participate in everyday environments. In FND, a change in symptom frequency is relevant insofar as it changes what a person can do, but functional recovery is multidimensional. A person may report fewer tremors while remaining unable to return to work; another may continue to experience episodes and nevertheless regain substantial independence. The WHO's International Classification of Functioning, Disability and Health differentiates body functions, activities, participation, and environmental facilitators or barriers. This distinction allows rehabilitation to evaluate more than symptom counts.
A multidisciplinary program combines clinical perspectives that examine different dimensions of one patient's condition. Neurology establishes and communicates the positive neurological diagnosis, monitors clinical changes, and addresses coexisting disease. Physiotherapy analyzes movement and builds automatic motor performance; occupational therapy examines daily activities and environmental demands; psychology and psychiatry assess coping, psychological symptoms, dissociation, and behavior; speech and language therapy addresses relevant functional communication and swallowing difficulties; nursing, social work, and rehabilitation medicine support safety, participation, and continuity. A program is interdisciplinary when these activities are tied to shared goals and coordinated explanations rather than offered as unrelated referrals.
Multidisciplinary care is consequently a service arrangement and a theory of change. Its hypotheses are that consistent explanation reduces uncertainty, task-relevant repetition increases fluent performance, attention and expectation can be modified through experience, and jointly negotiated goals make restored skills generalizable. Each hypothesis requires outcomes and controls appropriate to its specific mechanism. A coordinated team is clinically plausible, but the mere presence of several disciplines does not establish that their combination is superior to well-delivered single-discipline care.
Historical Development of the Field
Historical labels such as hysteria, conversion disorder, psychogenic movement disorder, and nonepileptic attacks reflect successive attempts to understand symptoms crossing the conventional boundaries of neurology and psychiatry. Nineteenth- and twentieth-century accounts offered psychodynamic, neurological, and behavioral explanations; clinical terminology often carried assumptions about causation. Contemporary FND literature places greater emphasis on demonstrable positive signs, phenomenology, learning, and the interactions of brain function with attention and expectation. The transition is summarized in Espay et al. (2018) (https://doi.org/10.1001/jamaneurol.2018.1264). Source 3
Rehabilitation has its own historical development. Conventional neurological physiotherapy was initially adapted to patients with functional weakness, gait difficulties, and tremor. Clinicians observed that movement quality could change with attentional focus, dual tasking, and context. Nielsen et al. (2015) (https://doi.org/10.1136/jnnp-2014-309255) translated such experience into international consensus recommendations for functional motor disorder, explicitly drawing upon specialist knowledge rather than claiming that every proposed technique had been established in controlled trials. Nicholson et al. (2020) (https://doi.org/10.1136/jnnp-2019-322281) and Baker et al. (2021) (https://doi.org/10.1136/jnnp-2021-326767) subsequently elaborated occupational and speech-language approaches. Source 9 Source 8 Source 1
The trial era introduced a necessary correction to early enthusiasm. A feasibility trial demonstrated that specialist physiotherapy could be delivered and studied; the later multicenter Physio4FMD trial tested whether such therapy improved an explicitly specified physical-functioning outcome relative to routine neurological physiotherapy. Its primary comparison was not significant. This history matters because it replaces a simple narrative of therapeutic progress with a more precise question: which program components produce which outcomes, in which patients, under which delivery conditions?
Diagnosis as the Entry Point to Rehabilitation
A diagnosis is clinically useful when the clinician can explain the positive findings that support it. Functional weakness may display internally inconsistent strength across tasks; some functional tremors change with entrainment or distraction; characteristic examination patterns can support a diagnosis of functional gait disorder. The findings and their interpretation depend on phenotype and clinical expertise. FND can coexist with structural neurological disease, which must remain visible in assessment and follow-up. Espay et al. (2018) (https://doi.org/10.1001/jamaneurol.2018.1264) describe the shift toward rule-in clinical features rather than diagnosis by exclusion alone. Source 3
The diagnostic conversation has a rehabilitative function. It gives an intelligible description of the symptoms, identifies observed capacity for change, explains why an intervention might address function, and creates a shared vocabulary for the team. The communication must acknowledge that symptoms are experienced as involuntary and may cause profound disability. Demonstrating a change in movement with distraction can show preserved movement capacity; it cannot by itself establish the patient's conscious control of the symptom or a universal cause of FND.
Rehabilitation should begin with an assessment of severity, safety, comorbid medical conditions, functional seizures when present, pain, fatigue, sleep, falls, medication burden, and psychosocial resources. New or changing neurological signs require appropriate clinical reassessment. The scope of this chapter concerns the connection between diagnosis and a rehabilitation plan; detailed differential diagnosis belongs to clinical neurology and diagnostic medicine.
Mechanistic Models of Motor and Sensory Symptoms
Predictive-processing and Bayesian models explain perception and action as context-sensitive inferences shaped by prior expectations and incoming sensory evidence. Edwards et al. (2012) (https://doi.org/10.1093/brain/aws129) proposed that abnormal weighting of expectations and sensation, modulated by attention, can contribute to functional motor and sensory symptoms. This is a theoretical framework rather than a diagnostic biomarker or a demonstrated explanation of every patient's symptoms. Its rehabilitation value lies in testable predictions: changing attentional demands, environmental cues, or sensorimotor feedback could modify symptom expression under defined conditions. Source 2
Complementary models emphasize maladaptive learned movement patterns, disrupted sense of agency, habitual avoidance, symptom monitoring, and changes in motor automaticity. These are separable levels of explanation. A patient can experience involuntary movements while also learning new motor strategies. A behavioral account of maintaining factors does not entail a claim that the symptom was voluntarily created. Psychological stress may shape illness experience, and some patients report trauma or adversity, but neither is a required individual explanatory variable.
Models should be evaluated by specifying their measurable predictions. Movement kinematics, dual-task performance, symptom variability, task-related neural measures, expectation manipulations, and change across repeated training sessions can test different aspects of them. Causal claims require controlled manipulations and a relevant comparison, while neuroimaging associations identify potential correlates. The most useful model is one that improves prediction and intervention design without erasing biological, psychological, or social heterogeneity.
Attention, Expectancy, and Motor Automaticity
Attention is central to many specialist motor rehabilitation approaches. Self-focused monitoring of a movement can be associated with effortful performance and altered symptom expression; shifting attention toward an external task or goal may facilitate a more fluid motor sequence. The functional significance of attention depends on symptom phenotype, context, and instructions. In specialist physiotherapy, therapists may use rhythmic actions, goal-directed tasks, or altered attentional focus while observing movement quality. These techniques form part of Nielsen et al.'s (2015) consensus (https://doi.org/10.1136/jnnp-2014-309255). Source 9
Expectations influence how patients interpret symptom changes, treatment credibility, and future capacity. A credible explanation and successful movement experiences may increase confidence; expectation alone is not a sufficient account of recovery. Clinicians and researchers should distinguish expectancy as a mediating candidate from expectancy as a source of reporting bias in nonblinded intervention studies. These roles can coexist.
The study of automaticity also clarifies why long-term transfer matters. Performance in a guided session does not necessarily predict performance under fatigue, stress, divided attention, or unfamiliar surroundings. A robust treatment model must examine whether skills generalize from the therapeutic encounter to ordinary movement and participation. Objective measures can support this analysis when they are feasible and appropriately validated.
Biopsychosocial Formulation and Individual Heterogeneity
The biopsychosocial model provides a framework for integrating symptom experience with illness history, functional demands, cognitive processes, physical health, social support, and environmental obstacles. Its practical strength is individual formulation: which mechanisms and barriers currently matter to this patient's goals? Its weakness appears when broad language substitutes for a specified mechanism. A formulation must remain empirically revisable when the patient's response differs from the initial hypothesis.
Comorbid anxiety, depression, chronic pain, fatigue, sleep disturbance, epilepsy, migraine, and autonomic symptoms can influence rehabilitation goals and tolerability. Their presence warrants independent assessment, because treatment of a comorbidity may improve well-being without resolving functional motor symptoms. Conversely, improvement in motor capacity may allow a patient to participate more actively despite continuing pain. This is the rationale for separating primary symptoms, coexisting health conditions, and functioning as distinct endpoints.
An individualized pathway also recognizes socioeconomic conditions, caregiving responsibilities, housing accessibility, health-system access, language, disability accommodations, and previous experiences with clinicians. A useful service model makes these factors explicit rather than treating nonattendance or limited progress as an individual motivational deficiency. Outcomes from specialist services may be difficult to generalize to patients without comparable access, income, or support.
Physiotherapy: Principles and Therapeutic Targets
Specialist physiotherapy for functional motor disorder is organized around retraining movement in a context of understandable diagnosis, collaborative goal setting, and attention to automatic motor performance. Nielsen et al. (2015) (https://doi.org/10.1136/jnnp-2014-309255) describe education, demonstration of preserved capacity, movement retraining, and self-management as consensus components. Gait, balance, limb movement, and functional transitions can become the practical settings for training. The therapist's target is useful movement under real demands, rather than correction of a putative anatomical lesion. Source 9
Several design choices distinguish functional motor rehabilitation from generic strengthening alone. The therapeutic task is selected because it can elicit a more effective action; attention may be directed toward a goal or external stimulus; repetition helps the patient develop a stable alternative response; and the new pattern is incorporated into meaningful activity. If pain or fatigue is present, pacing and adaptive workload are considered as part of the clinical formulation. Research should disentangle how much benefit follows from general exercise, task practice, specific attentional techniques, therapeutic alliance, or education.
Safety requires clinical judgment in patients with frequent falls, episodes of altered awareness, high fatigue, mobility limitations, or coexisting neurological and orthopedic conditions. A rehabilitative model should specify methods of adverse-event monitoring and appropriate escalation when the clinical presentation changes. Consensus recommendations inform specialist practice but are not themselves comparative proof of effectiveness.
Functional Gait and Balance Retraining
Functional gait disorder may present with variable walking speed, inconsistent balance, atypical postural responses, and marked discrepancies between different tasks. Rehabilitation research must distinguish these observable features from the patient's internal experience of control, which may remain profoundly disrupted. The immediate therapeutic question is whether a task can reveal a more effective movement strategy that can be practiced safely and transferred to ordinary environments.
Specialist training may incorporate walking with a different attentional focus, rhythm, graded complexity, and practice of daily transitions. The Nielsen et al. consensus (https://doi.org/10.1136/jnnp-2014-309255) addresses such techniques in a broader motor-retraining framework. A useful protocol records what is practiced, how much support is provided, whether the task is performed in a clinic or community setting, and what changes when supervision is reduced. Mobility gains must be distinguished from temporary performance under close therapist guidance. Source 9
Measurement should include patient-valued destinations, safe walking in relevant conditions, use of mobility aids when indicated, and participation in chosen activities. Assessment of falls risk remains a clinical responsibility. Research comparing techniques must use meaningful controls, monitor worsening or injury, and acknowledge that functional gait disorder includes varied symptom patterns rather than one uniform presentation.
Functional Tremor, Weakness, and Other Movement Phenotypes
Functional tremor and weakness illustrate the challenge of linking positive diagnostic signs to treatment mechanisms. A tremor may alter its frequency during a second rhythmic task, and apparent weakness may vary across automatic and effortful movement. Such phenomena support clinical interpretation when appropriately examined, but they do not guarantee that a particular attentional exercise will produce durable improvement. The inferential step from diagnostic sign to treatment response requires independent study.
Motor rehabilitation protocols should specify phenotype, baseline movement characteristics, coexisting musculoskeletal conditions, and the intended mechanism of training. For some patients, graded restoration of ordinary limb use may be the central goal. Others require coordination of multiple tasks or adaptation to variable fatigue. A rigorous evaluation records objective task performance when possible alongside symptom experience, perceived control, and life participation.
Comparative studies should stratify by motor phenotype or prespecify subgroup analyses, because a broad functional motor disorder category includes clinically distinct presentations. Treatments delivering equal clinician time and clear diagnostic explanation would provide stronger evidence for the additional value of specific movement techniques. The pragmatic Physio4FMD trial is foundational here because its active comparator prevents the inference that specialist content automatically explains all observed improvement.
Early Feasibility Evidence for Physiotherapy
The Nielsen et al. (2017) randomized feasibility study (https://doi.org/10.1136/jnnp-2016-314408) compared a specialist physiotherapy approach for patients with functional motor symptoms with usual care. Its main contribution was demonstrating the feasibility and acceptability of a structured specialist intervention, providing an empirical rationale for a larger definitive trial. A feasibility design addresses recruitment, delivery, outcome measurement, and trial procedures; it is poorly suited to establish a final estimate of comparative treatment efficacy. Source 10
Early positive observations from controlled and uncontrolled rehabilitation studies need interpretation in light of selection, expectation, unequal treatment intensity, concurrent care, regression toward the mean, and the possibility of spontaneous changes. A participant's perceived improvement is meaningful but should be considered alongside functional outcomes and prespecified endpoints. Blinded assessment may be possible for some behavioral tasks even when participants know which therapy they receive.
The field's development from small studies toward more rigorous multicenter comparisons shows how clinical innovation and evidence evaluation can proceed together. Treatment protocols become reproducible research objects when their core components, therapist training, allowed adaptations, cointerventions, dose, and follow-up procedures are described clearly.
Physio4FMD: The Pivotal Multicenter Trial
The Physio4FMD phase 3 randomized trial (https://doi.org/10.1016/S1474-4422(24)00135-2) enrolled adults with clinically definite functional motor disorder across 11 hospitals in England and Scotland. The comparison was a protocolized specialist physiotherapy intervention of nine sessions plus follow-up against referral to local community neurological physiotherapy. This is an active-care comparator, which tests the added value of specialist intervention beyond a relevant alternative rather than measuring treatment against no care. Source 11
The 2025 Health Technology Assessment report (https://doi.org/10.3310/MKAC9495) records 355 randomized adults, with 179 assigned to specialist physiotherapy and 176 to treatment as usual. The primary 12-month outcome was the SF-36 physical functioning domain. The adjusted mean difference was 3.5 points, with a 95% confidence interval from −2.3 to 9.3; the primary comparison did not establish superiority. Several secondary measures favored specialist physiotherapy, including patient-perceived improvement, mental health, diagnostic confidence, and aspects of illness perception. These secondary findings offer important hypotheses, but interpretation should acknowledge multiple comparisons and self-report susceptibility to treatment expectation. Source 12
The trial also exposed operational complexities. COVID-19 disruption excluded 89 randomized participants from the prespecified primary analysis because they could not receive allocated treatment; outcome retention among the remaining eligible participants was reported as 90%, with 241 in the primary analysis. The usual-care group experienced longer waits, changing the relation between intervention completion and outcome assessment. Thus, the most defensible synthesis is that specialist physiotherapy was feasible and yielded some favorable secondary outcomes, while superiority on the prespecified long-term physical functioning measure was unconfirmed. It would be inaccurate to transform secondary improvement into an unqualified claim of primary efficacy.
Treatment Dose, Fidelity, and Competence
The dose of rehabilitation includes much more than the number of scheduled appointments. Relevant components include duration, frequency, practice between visits, therapist feedback, intensity of daily activity, and the time a patient has to consolidate newly learned skills. Two programs with the same session count can differ greatly in content and accessibility. The nine-session specialist protocol used in Physio4FMD provides one operationally explicit model but does not establish a universally sufficient dose.
Treatment fidelity describes whether an intervention was delivered according to its protocol. In complex multidisciplinary programs, fidelity can be evaluated by documentation of diagnostic explanation, specified therapeutic tasks, goal review, coordination meetings, and patient practice. Competence concerns how skillfully these elements are delivered. Both matter to causal interpretation: a treatment may fail because an assumed mechanism is ineffective, because a protocol was poorly implemented, or because an outcome did not measure the intended change.
Future dose-response research could randomize feasible intensity variants, while carefully recording adherence and cointerventions. Intensity also has costs and possible harms, especially in patients with fatigue, pain, unstable mobility, limited transportation, or competing caregiving demands. More treatment is therefore a hypothesis, not an automatic clinical advantage.
Interpreting Comparative Effectiveness and Health Economics
Clinical-effectiveness claims must specify a comparator and an outcome. Specialist physiotherapy may differ from usual community physiotherapy in content, accessibility, therapist training, intensity, and treatment timing. A favorable result against waiting-list control would answer a different question from a favorable result against active rehabilitation. Physio4FMD directly addresses a clinically relevant active comparator, so its primary null result is central to current interpretation.
Economic assessment provides a second and distinct question. The Physio4FMD Health Technology Assessment (https://doi.org/10.3310/MKAC9495) concluded that specialist physiotherapy had a high probability of being cost-effective within the study's analytic assumptions. Cost-effectiveness combines costs and health-related outcomes, often through quality-adjusted life-years, and is not interchangeable with a significant difference on the primary clinical endpoint. Its applicability depends on local health-system prices, waiting times, patient mix, and whether modeled improvements persist in routine care. Source 12
Research on complex interventions should report treatment fidelity, provider experience, access, additional health-service use, adherence, and reasons for dropout. Independent economic analyses should examine sensitivity to resource use and missing data. Better clinical endpoints may capture everyday mobility and participation more meaningfully than a single broad self-report scale; such endpoints require validation before serving as primary outcome measures.
Occupational Therapy and Everyday Participation
Occupational therapy focuses on activities that organize an individual's daily life: self-care, domestic tasks, education, employment, social participation, and the balance between activity and rest. The Nicholson et al. (2020) international consensus (https://doi.org/10.1136/jnnp-2019-322281) proposes education, functional activity practice, self-management, goal setting, practical management of pain and fatigue, and reduction of unnecessary dependency. The paper was developed through expert surveys, multidisciplinary discussion, and iterative agreement; its evidential status is consensus guidance. Source 8
Activity-based goals can reveal barriers missed by clinic-based motor tests. A patient may improve standing or reaching during therapy yet remain unable to prepare meals because of sustained fatigue, inaccessible equipment, or fear of unpredictable symptoms. Occupational assessment explores how these difficulties are patterned across contexts, and whether task modification, graded practice, family collaboration, or environmental accommodation changes performance. Appropriate accommodations are compatible with rehabilitation because participation and safety are independently valuable outcomes.
Recommendations concerning assistive devices are particularly context-sensitive. Some specialists caution against unnecessary immobilization or equipment that inadvertently reinforces inefficient movement patterns during active retraining, but required mobility aids and disability supports must be judged against falls risk, accessibility, participation, and patient choice. Their withdrawal or modification is a clinical decision, and no consensus document proves that a single strategy suits every stage and level of disability.
Sensory Symptoms, Dizziness, and Multisymptom Rehabilitation
Functional sensory symptoms, dizziness, visual complaints, and other nonmotor presentations can affect activity even when limb movement appears relatively preserved. Rehabilitation pathways for these symptoms require careful assessment and differential diagnosis and may draw on different disciplines than motor rehabilitation. The scientific category of FND encompasses multiple phenotypes; findings from trials in functional motor disorder cannot simply be transferred to all sensory or episodic symptoms.
From a rehabilitation perspective, the important constructs include symptom variability, attentional orientation, avoidance, confidence in daily tasks, environmental complexity, and participation. Intervention hypotheses may involve graded exposure to relevant activity, restoration of task confidence, and adaptive use of sensory information. These must be distinguished from established evidence for each phenotype, since some proposed techniques remain supported mainly by theory or clinical experience.
Future studies should describe symptom groups separately, report coexisting vestibular, visual, medical, or neurological conditions when relevant, and measure the activity actually affected. Treating several symptoms within one multidisciplinary service is practical, but it should not hide variation in diagnostic confidence, safety requirements, treatment response, and outcome validity.
Speech, Voice, Swallowing, and Communication Rehabilitation
FND may present with functional speech, voice, language-related, cough, or swallowing symptoms, each requiring careful phenotype-specific assessment. Baker et al. (2021) (https://doi.org/10.1136/jnnp-2021-326767) assembled expert consensus recommendations for speech and language professionals. Their account links education and symptomatic rehabilitation with attention, movement patterns, illness beliefs, and a supportive therapeutic relationship. Source 1
Communication and swallowing are socially consequential functions. Speech difficulty can undermine work participation, identity, and access to other health services; swallowing symptoms can create nutritional and safety concerns that require appropriate medical evaluation. A communication intervention must distinguish symptom-specific improvement from return to social participation and must track unintended harm or distress. The evidence base contains clinical expertise and smaller observational reports, but high-quality comparative trials are comparatively sparse.
The role of speech and language therapy illustrates why FND rehabilitation cannot be reduced to a uniform motor protocol. Techniques must follow the mechanism and the actual difficulty observed, whether fluent speech, voice production, safe swallowing, or cough. Cross-discipline coordination prevents contradictory explanations and allows improvements in one area to be incorporated into occupational and family settings.
Psychological Therapies and Their Mechanistic Roles
Psychological treatments can address avoidance, anxiety, depressive symptoms, dissociation, coping, self-efficacy, distress associated with symptoms, and patterns of behavioral response. Cognitive behavioral therapy (CBT) is one studied approach, but protocols vary by phenotype and are not interchangeable. Psychological intervention is a component of rehabilitation when its goals connect to function and quality of life, and its indication is based on formulation rather than an assumption that all patients share one psychological cause.
The rationale is behavioral and clinical: identifying triggers, responses, and consequences can make daily functioning more predictable; behavioral experiments can test assumptions about symptom exacerbation and safety; coordinated pacing may address boom-and-bust cycles; and psychotherapy can treat independently diagnosed psychiatric conditions. Outcome assessments should separate changes in mood from changes in motor or seizure symptoms. Patient preferences, accessibility, and prior therapeutic experiences influence engagement.
The best evidence for CBT within FND comes substantially from research on functional or dissociative seizures, while motor rehabilitation trials have evaluated distinct interventions. Any argument that CBT improves all FND symptoms must therefore specify whether it rests on direct controlled evidence, observational extension, or theoretical analogy. The diagnostic communication of FND should never make access to neurological and physical rehabilitation contingent upon accepting a narrow causal narrative.
Functional Seizures and the CODES Trial
Functional or dissociative seizures are episodes that can resemble epileptic seizures but have a different underlying clinical mechanism; epilepsy and functional seizures may coexist. Their diagnostic and treatment pathways require competent neurological assessment and often collaboration with mental-health professionals. Rehabilitation outcomes include episode burden, safety, emergency-department use, functioning, stigma, psychosocial distress, and participation, rather than seizure frequency alone.
The CODES multicenter randomized trial (https://doi.org/10.1016/S2215-0366(20)30128-0) randomly assigned 368 adults with dissociative seizures to CBT plus standardized medical care or standardized medical care alone. At 12 months, the principal monthly seizure-frequency outcome showed no statistically significant between-group difference: the reported estimated incidence rate ratio was 0.78, 95% CI 0.56–1.09, p = .144. Some secondary outcomes favored CBT plus standardized care, including aspects of psychosocial functioning and seizure-related experiences. The primary negative result and the secondary signals must both remain part of the scientific account. Source 4
The earlier LaFrance et al. (2014) pilot trial (https://doi.org/10.1001/jamapsychiatry.2014.817) randomized 38 patients, of whom 34 were included in analysis, among four intervention arms. It reported substantial within-group seizure reductions in psychotherapy arms over the trial period, but the study was small and not powered to detect definitive between-arm differences. Small pilot findings generate treatment hypotheses; CODES provides a larger and more rigorous test of a particular CBT-based program. The two studies are consistent in making treatment development worthwhile while resisting an overgeneralized claim of proven seizure-frequency superiority. Source 6
Psychiatry, Comorbidity, and Medication Stewardship
Psychiatric assessment is relevant when anxiety disorders, depressive disorders, post-traumatic symptoms, dissociation, substance-use problems, or other mental-health conditions are present. Treatment of those conditions can improve distress and participation independently of FND symptom resolution. The severity and urgency of psychiatric needs are clinical matters requiring direct assessment, especially when there is acute safety concern.
There is no established medication that specifically reverses the core mechanism of FND across its phenotypes. Drug treatment may be used for separate, documented indications and should be evaluated for benefit, adverse effects, sedation, dependence risk where applicable, interactions, and effects on participation. Medication recommendations must follow current regulatory labeling and clinical guidance for the actual indication. An FND label alone cannot justify prescribing, escalating, or abruptly discontinuing a drug.
In functional seizures, treatment changes involving antiseizure medication demand particular care because coexisting epilepsy may be present. Such decisions are made by the responsible clinical specialist after diagnostic assessment. In a multidisciplinary model, medication review, physical rehabilitation, psychological treatment, and medical follow-up form coordinated but distinct domains.
Pain, Fatigue, Sleep, and Somatic Comorbidity
Pain and fatigue frequently complicate rehabilitation because they constrain the intensity, timing, and perceived costs of activity. A treatment focused only on improving motor mechanics may appear successful in the clinic while failing to improve the individual's daily life. Clinically useful assessment therefore records fatigue variability, sleep quality, physical conditioning, pain interference, and the patient's priorities, rather than using symptom presence as a single explanatory category.
Different problems require different strategies. Persistent pain may call for evidence-based pain management and function-oriented pacing. Fatigue may require adjustment of practice dose, sleep evaluation, and sustainable scheduling. Sleep disturbance and medication effects may independently change symptom tolerance. The theoretical expectation is that improved self-management can increase participation even before every symptom resolves; controlled evidence on the effectiveness of specific packages in FND remains limited.
In research, pain and fatigue should be modeled as baseline modifiers, cointerventions, and outcomes. Improvement on a broad health scale can be driven by changes outside the target motor symptom. Conversely, an intervention can reduce a specific motor symptom while leaving fatigue and overall quality of life unchanged. Both patterns are informative and should be reported separately.
Family, Caregivers, and Relational Processes
Close relationships influence how symptoms are interpreted, how daily responsibilities are allocated, and whether patients can practice newly acquired skills outside therapy. Family members may provide transport, emotional support, accessibility modifications, practical assistance, and crucial safety monitoring. In some situations, patterns of overprotection or conflict may complicate self-management, but these possibilities must be investigated individually rather than presumed.
The Nicholson et al. (2020) recommendations (https://doi.org/10.1136/jnnp-2019-322281) include involvement of significant others in education and treatment where appropriate. Collaboration requires patient consent and protection of autonomy. Families benefit from consistent explanations that recognize symptoms as genuine and support negotiated goals, realistic accommodations, and sustainable caregiving. The objective is shared understanding and participation without transferring all responsibility for improvement to relatives. Source 8
Family involvement is an underdeveloped empirical research domain. Appropriate trials would distinguish family education alone from broader packages, measure caregiver burden and patient participation, and assess possible harms such as anxiety, surveillance of symptoms, or conflict around activity. Studies must accommodate different household structures and cultural understandings of care.
Goal Setting, Agency, and Self-Management
Rehabilitation goals translate theory into behavior that can be observed and evaluated. A useful goal specifies an activity important to the patient, the context in which it is performed, and the level of assistance or effort required. Walking to a local shop, communicating with a work team, preparing a meal, or attending a class gives a concrete anchor for assessment. Symptoms can remain relevant but should not displace the person's own definition of meaningful progress.
Agency is the capacity to influence one's activities and choices under actual conditions of illness and environment. A patient's sense of agency may be diminished by involuntary symptoms, repeated invalidation, or inaccessible services. Collaborative planning restores some decision-making capacity by making the rationale for tasks understandable and giving the patient a voice in priorities, pacing, and evaluation. It is conceptually important to distinguish restored decision-making from control over involuntary symptom production.
Self-management includes recognizing fluctuations, applying practiced strategies, anticipating situations that require accommodations, and arranging follow-up. It is measured through retained skills and life participation, not merely a clinician's assessment of enthusiasm. Interventions should make room for varying capacities, disability support, and episodic relapse without framing recurrence as personal failure.
Vocational, Educational, and Community Reintegration
Return to work, school, family roles, and community participation can be among the most consequential outcomes of FND rehabilitation. These activities depend on more than clinical symptom control. Work schedules, sensory environments, mobility access, transportation, interpersonal expectations, and disability accommodations can determine whether regained capacities become sustainable. Rehabilitation goals should therefore include environmental opportunities and constraints.
Vocational and educational outcomes require explicit measurement. Researchers can examine attendance, role satisfaction, modified duties, supported transitions, and sustained participation, rather than relying exclusively on whether a person is formally employed or enrolled. A person who returns to a modified workload may have achieved a meaningful improvement even when symptom frequency remains unchanged. Employer and school collaboration should be based on consent, privacy, and the individual's chosen goals.
Service models need bridges to occupational health, social services, education, disability benefits systems, and community organizations. These connections extend rehabilitation beyond the clinic and test its ecological validity. The question is whether treatment changes life possibilities over time, rather than merely improving a short-term score measured at discharge.
Inpatient, Day-Program, Outpatient, and Community Models
Rehabilitation can be delivered in inpatient units, intensive day programs, ordinary outpatient services, home-based care, and telehealth-supported arrangements. These formats differ in treatment intensity, professional availability, travel burden, continuity, and capacity to respond to safety needs. A service model must specify which interventions are provided, how often, by whom, and with what support after discharge.
Intensive programs may permit concentrated team interaction and repeated practice within a controlled environment, whereas community programs offer greater ecological validity and easier transfer to ordinary routines. These advantages are hypotheses to be evaluated, not assumed comparative outcomes. Differences in referral criteria, illness duration, functional severity, and access to specialized clinicians complicate comparison across cohorts.
An effective transition plan coordinates the neurologist, therapists, primary care, community support, and relevant educational or vocational services. It should make the diagnosis and intervention rationale legible to the receiving team while preserving privacy. Future work needs pragmatic multicenter comparisons across service levels, including costs and participation outcomes, rather than relying on before–after improvement in highly selected specialist cohorts.
Pediatric and Adolescent Rehabilitation
Children and adolescents with FND present distinct developmental, family, school, and safeguarding considerations. Pediatric programs frequently integrate medical assessment, physical rehabilitation, psychological care, caregiver engagement, and return-to-school planning. Their targets include attendance, social participation, age-appropriate autonomy, and family functioning alongside symptoms. Adult treatment parameters cannot simply be transferred to younger populations.
The review by Vassilopoulos and colleagues (2022) (https://doi.org/10.1007/s11940-022-00708-5) describes pediatric treatment approaches, including multidisciplinary rehabilitation, drawing on prospective and retrospective program studies. Some pediatric cohorts report high remission proportions, but the designs and service contexts make direct causal interpretation difficult. Referral selection, developmental stage, symptom mix, family resources, and follow-up timing all shape observed outcomes. Source 15
Research on younger patients needs developmentally validated measures, school outcomes, family-reported and patient-reported experience, adverse-event surveillance, and long-term follow-up into adult services. Clinical decisions should remain specific to pediatric practice, with qualified professionals addressing diagnostic uncertainty and safeguarding where relevant.
Patient Experience, Stigma, and the Therapeutic Alliance
Patient experience affects rehabilitation access, trust, continuation, and meaningful outcome measurement. People with FND often describe delayed diagnosis, difficulty obtaining specialist care, and explanations that seem to deny the reality of their symptoms. Qualitative investigations of stigma and health-service trajectories make these barriers visible, although interview samples are not designed to estimate population prevalence. The 2024 study of how stigma unfolds (https://doi.org/10.1016/j.jpsychores.2024.111667) explored 15 interviews and described stigma arising in clinical encounters, everyday relationships, and self-perception. Source 7
A therapeutic alliance requires accurate information, respectful listening, transparent disagreement where appropriate, and shared goals. Diagnostic acceptance should not be inferred from silent compliance. Patients may reasonably ask how a treatment works, why one approach is prioritized, and what happens if it fails. Programs can measure perceived validation, satisfaction, accessibility, and participation alongside clinical outcomes.
The more recent qualitative study of diagnostic and care journeys (https://pmc.ncbi.nlm.nih.gov/articles/PMC13102217/) analyzed 18 interviews and described obstacles to obtaining support and navigating life after diagnosis. Such findings identify service problems and generate candidate intervention targets, but they cannot determine treatment efficacy. They nevertheless matter because a biologically plausible therapy that patients cannot access or trust may have little population-level impact.
Adverse Events, Deterioration, and Clinical Safety
Safety is an independent outcome of rehabilitation. Functional symptoms may fluctuate and can be accompanied by falls, severe fatigue, pain, dissociative episodes, mobility limitations, and acute medical concerns. A scientific account should evaluate potential deterioration or unintended dependence as carefully as improvement. An intervention may enhance performance during supervised treatment while leaving a person vulnerable in ordinary settings.
Adverse-event reporting is especially important where interventions involve graded physical activity, reduction of external supports, challenging situations, or changes to patterns of assistance. Study reports should state who collected safety information, how worsening was defined, and whether events were plausibly related to treatment. The absence of reported adverse events is not equivalent to proof that they were systematically assessed and absent.
Clinical reassessment is essential when symptoms evolve or an additional neurological condition is suspected. Rehabilitation decisions about mobility aids, activity intensity, swallowing concerns, and emergency management belong with qualified clinicians who know the patient. For research, clearly specified escalation procedures and harms reporting strengthen both interpretability and ethical accountability.
Outcome Measures and Construct Validity
Outcome choice is a scientific decision about what rehabilitation means. Symptom counts, self-rated improvement, clinician-rated global change, physical functioning, functional independence, quality of life, workplace participation, school attendance, and healthcare use represent different constructs. Their convergence is informative; their disagreement exposes gaps in theory or measurement. The International Classification of Functioning encourages researchers to capture activity and participation alongside symptom change.
The Physio4FMD trial illustrates this issue directly. Its prespecified SF-36 physical functioning endpoint was not significantly different at 12 months even though several secondary self-report measures favored the specialist intervention. A sound interpretation must preserve the hierarchy of outcomes, assess precision through confidence intervals, and consider the influence of unblinded treatment allocation. Neither a null primary result nor positive secondary measures alone provide a complete account of treatment experience.
Future measurement work should examine reliability, responsiveness, minimally important difference, cross-cultural equivalence, floor and ceiling effects, and whether mobility tests predict participation. Objective activity metrics, ecological assessment, and individual goal attainment may complement established scales. Researchers should predefine their priority outcome and avoid retrospective promotion of favorable measures.
Study Designs and Causal Interpretation
The FND rehabilitation evidence base spans expert consensus, uncontrolled prospective cohorts, retrospective service evaluations, qualitative interviews, feasibility studies, randomized clinical trials, and systematic reviews. Each design answers a different question. Consensus can codify practice; cohort studies describe change under observed care; qualitative studies clarify experience; randomized comparisons estimate effects under the conditions of a trial. A synthesis becomes misleading if all designs are assigned the same inferential weight.
For nonrandomized rehabilitation studies, regression to the mean, natural fluctuation, selective referral, differential attrition, concurrent therapies, expectation effects, and outcome choice can distort treatment estimates. Small samples and highly specialized teams also make generalization uncertain. In randomized trials, treatment fidelity, contamination, unequal contact, missing observations, crossovers, allocation concealment, and assessor masking require attention.
A modern evidence architecture should pre-register protocols and specify treatment ingredients, outcomes, duration, eligibility, adverse events, and analysis strategy. Multicenter pragmatic trials can measure comparative effectiveness, while embedded mechanistic studies test why an intervention may work. Qualitative and implementation research then investigate acceptability, equity, and whether the model can operate outside a specialist center.
Research Transparency and Evidence Certainty
The confidence assigned to any FND intervention estimate should reflect design, execution, precision, consistency, and directness to the intended clinical question. Small uncontrolled studies can show that improvement occurred but cannot isolate a causal treatment effect. Randomized controlled trials address comparison more directly, yet unblinded self-report, missing observations, unequal waiting times, and heterogeneous outcomes may weaken inference. Systematic reviews inherit limitations from their included studies.
In Keatley et al. (2026) (https://doi.org/10.1176/appi.neuropsych.20250222), the reported improvement proportion combines studies of different interventions and populations; its magnitude should not be read as the effect size of multidisciplinary care. The subset of randomized trials allows a different inference but remains limited in size and diversity. A meaningful evidence statement must name the outcome: support may be stronger for changes in some symptoms than for sustained differences in physical function. Source 5
Transparent scholarly reporting should describe search coverage, protocol status, eligibility criteria, source accessibility, competing interests, and which conclusions derive from direct inspection of an original paper versus an abstract or secondary summary. This monograph uses a critical narrative method, and no formal GRADE scoring has been undertaken. Any future systematic update should register its methodology and report a reproducible risk-of-bias procedure.
Synthesis of Rehabilitation Evidence Through 2026
The 2026 systematic review and meta-analysis by Keatley and colleagues (https://doi.org/10.1176/appi.neuropsych.20250222) offers a recent synthesis focused on rehabilitation trials rather than psychotherapy-only studies. Its abstract reports 30 included articles comprising 1,581 participants. Across rehabilitation trials, an estimated 74% experienced clinical improvement in a meta-analysis of proportions, with substantial variation across studies. This proportion is a pooled descriptive result from heterogeneous treatments and designs, not the probability of benefit caused by a particular program compared with no treatment. Source 5
The same synthesis reported positive pre–post effects for FND symptoms and physical function in 23 studies supplying the required data. In the subset of seven available randomized trials, a pooled treatment effect was found for FND symptoms, whereas effects on physical function, fatigue, and mental health did not reach statistical significance. These differences make it essential to separate within-person change from comparative treatment effect. The authors themselves note major heterogeneity in populations, protocols, and outcome measurement.
This aggregate evidence is compatible with specialist rehabilitation as a promising clinical research program and with uncertainty about its effectiveness on several patient-centered domains. It does not establish a universal rehabilitation package, the causal necessity of every multidisciplinary component, or uniform recovery prospects. Large trials such as Physio4FMD help specify where broad positive claims must be narrowed, while smaller studies continue to generate mechanistic and implementation questions.
Symptom Duration, Prognosis, and Follow-Up
Longer-standing symptoms may coincide with entrenched activity restrictions, medical comorbidity, social consequences, disability-related losses, and difficulty accessing specialist care. These factors make duration a potentially important prognostic variable, but symptom chronicity is not an intrinsic measure of willingness or recoverability. Research must distinguish pre-treatment prognosis from treatment-effect modification: a group that begins with greater disability may improve less without necessarily receiving a smaller causal effect.
A 2025 systematic review and meta-analysis on symptom chronicity (https://pubmed.ncbi.nlm.nih.gov/41070273/) evaluated outcomes across FND phenotypes. Its abstract reports 63 eligible studies and a meta-analysis of 27 studies comprising 885 participants. Longer duration was associated with modestly smaller improvements on some motor and physical quality-of-life scales, while improvements in other domains were also observed in longer-standing cases. The variation across interventions and phenotypes limits a single prognostic rule.
Follow-up should assess the durability of specific skills, independence, work and social participation, symptom recurrence, and new medical needs. Repeated measurements can detect fluctuating patterns and distinguish short-term therapeutic performance from sustained benefit. Rehabilitation research should avoid treating delayed recovery as proof that further support cannot help.
Equity, Implementation, and Health-System Design
Treatment efficacy is only one determinant of population benefit. Access depends on geographical distribution of specialist centers, clinician training, referral routes, insurance or public funding, disability-related transport barriers, digital access, and recognition of FND in health systems. Patients outside specialist pathways may receive delayed explanations and fragmented treatment. Service design therefore belongs within the research object of multidisciplinary rehabilitation.
Implementation studies should investigate whether a shared model can be delivered by community clinicians after structured training and supervision. The essential elements of a specialist package should be distinguished from optional adaptations. Outcomes should include referral-to-treatment time, dropout, equity across demographic groups, adverse events, patient experience, and cost. Qualitative research can expose institutional barriers that trial efficacy measures cannot capture.
Co-design with people living with FND can improve the relevance of goals and reduce avoidable stigma, while formal evaluation must determine whether these changes improve access or outcomes. The public-health question is how to provide coherent evidence-informed rehabilitation at scale, including long-term support for individuals who continue to experience disability.
Cross-Disciplinary Boundaries and the Artificial Era
FND rehabilitation intersects with rehabilitation psychology, clinical psychology, neuropsychology, neurology, occupational science, psychiatry, and health-services research. The shared scientific object is the interaction of symptom mechanisms with activity, agency, and participation. Separate research objects include the differential diagnosis of functional seizures and movement symptoms, treatment of chronic pain as its own condition, and general theories of functional cognition. Maintaining these distinctions prevents a single review from absorbing unrelated diagnostic or theoretical literatures.
Digital rehabilitation tools, wearable activity measures, telehealth, and AI-assisted documentation may support access, monitoring, and coordination. Their clinical value requires validation of privacy, measurement accuracy, fairness, safety, accessibility, and actual patient outcomes. The Artificial Era supplies an interdisciplinary context in which human–artificial systems may become part of rehabilitation infrastructure, but claims concerning artificial agency or psychological organization are conceptual propositions until supported by relevant operational research.
This boundary is consequential for evidence. Findings about human rehabilitation cannot simply be treated as evidence about artificial cognition, and technical demonstration of a digital tool cannot substitute for a clinical outcome trial. Digital interventions should be evaluated according to the same principles of comparative effectiveness and patient-centered validity as other rehabilitation components.
Integrating Evidence With Patient-Centered Care
Evidence-based rehabilitation is a joint undertaking in which research estimates, clinical expertise, and the patient's values must be interpreted in a specific context. A clinician can explain that some controlled trials show favorable outcomes while particular primary endpoints remain uncertain. The patient can then decide which meaningful function to prioritize, with appropriate medical guidance and accommodation for limited resources. This communication is part of informed participation in care.
For one person, the central outcome may be safe transfers and reduction of fall risk; for another, return to employment, a stable school schedule, or improved communication. The treatment program must identify which professional skills address the stated problem and whether the person's environment will support transfer. A multidisciplinary team serves the patient's goals through coordinated practice, rather than organizing the patient around professional departments.
The continuing task of science is to determine which components add value, when they do so, and for whom. Reliable answers require both controlled comparisons and close attention to the lived conditions of disability. This framework allows progress in symptoms, functioning, psychological well-being, and participation to be recognized accurately and evaluated without treating any single metric as an exhaustive measure of recovery.
Critical Scientific Discussion
The evidence supports several distinguishable conclusions. Specialist therapies have coherent clinical rationales and substantial practice-based literature. Feasibility and some symptom and patient-reported outcomes favor rehabilitation strategies in certain studies. Randomized trials and syntheses nevertheless reveal important unresolved effects on physical functioning, fatigue, and broader mental health. A careful account retains positive and null findings together and distinguishes mechanistic plausibility from comparative clinical benefit.
A fundamental methodological tension concerns treatment packages. Multidisciplinary programs combine diagnosis explanation, therapeutic relationship, movement practice, psychological strategies, occupational support, and coordinated follow-up. Observed improvement rarely identifies the active ingredient. Dismantling studies, factorial designs, and comparative effectiveness trials could test the contribution of individual components and their combinations. Such research is technically difficult because ingredients interact and standardized procedures must remain individualized enough for real clinical cases.
An equally important tension concerns outcome definition. Patients may value autonomy, participation, work capacity, and relief from stigma as much as symptom frequency. Researchers require a limited set of prespecified endpoints to avoid selective inference. This conflict can be resolved through explicit primary outcomes coupled with a core set of complementary patient-centered, functional, safety, and implementation measures, reported transparently even when they disagree.
The strongest current synthesis therefore describes multidisciplinary FND rehabilitation as a promising, heterogeneous clinical field with credible mechanisms and meaningful patient experience, whose comparative effectiveness varies by phenotype, intervention, comparator, and measured domain. Future confidence depends on independent multicenter replication, phenotype-specific treatment models, longer follow-up, more diverse samples, and better-validated outcomes.
Research Priorities and Testable Questions
A coherent research program begins with causal questions. Does focused movement retraining improve objective functional mobility beyond matched general neurological physiotherapy? Does explicitly coordinated multidisciplinary care improve participation beyond equal-dose uncoordinated care? Which attentional or expectancy changes mediate improvement, and do experimentally induced changes predict transfer to everyday tasks? Does a tailored combination outperform a uniform package for defined subgroups?
Measurement questions are equally urgent. What are the most responsive validated activity and participation outcomes for functional motor disorder? How reliably can clinicians and patients report episodes, gait limitation, fatigue, and recovery? Which outcomes are most meaningful to patients and caregivers? Are improvements maintained at one, two, and five years, and how do relapse and fluctuating disability affect interpretation?
Health-system questions concern effectiveness under ordinary conditions. What level of specialist training is necessary for community delivery? Which formats are accessible to rural and economically disadvantaged populations? Can telehealth and digital tools preserve safety and effectiveness while reducing travel burdens? What adverse events, unintended dependencies, and financial harms should routinely be tracked? These questions should inform registered trials and implementation studies with transparent outcomes, not be treated as already answered.
Conclusion
Functional Neurological Disorder: Multidisciplinary Rehabilitation establishes a specific scientific domain at the intersection of neurological diagnosis, rehabilitative learning, psychological care, daily activity, and social participation. Its clinical logic centers on understandable diagnostic explanation, collaborative goals, symptom-appropriate retraining, coordinated management of comorbid conditions, and transfer of skills into the patient's actual environment. The WHO ICF provides a coherent framework for treating impairment, activity, participation, and environmental barriers as related but distinct dimensions.
The contemporary evidence is informative and uneven. Expert consensus has elaborated practical roles for physiotherapy, occupational therapy, and speech and language therapy. Randomized studies, including Physio4FMD and CODES, identify clinically important secondary improvements while finding no significant superiority on certain prespecified primary outcomes. The 2026 synthesis of rehabilitation trials reports favorable overall symptom signals together with heterogeneous studies and uncertain effects on broader functional domains. The responsible scientific conclusion is that intervention-specific comparative claims require intervention-specific evidence.
The next phase of the field should connect theory, patient priorities, and rigorous evaluation. Multidisciplinary care has the greatest scientific meaning when the mechanism, treatment elements, clinical population, outcomes, safety, and follow-up are precisely defined. Its enduring goal is reliable recovery or support of the person's capacity to live, act, and participate under real-world conditions.
References
- Baker, J., Barnett, C., Cavalli, L., et al. (2021). Management of functional communication, swallowing, cough and related disorders: Consensus recommendations for speech and language therapy. Journal of Neurology, Neurosurgery & Psychiatry, 92(10), 1112–1125. https://doi.org/10.1136/jnnp-2021-326767
- Edwards, M. J., Adams, R. A., Brown, H., Pareés, I., & Friston, K. J. (2012). A Bayesian account of ‘hysteria’. Brain, 135(11), 3495–3512. https://doi.org/10.1093/brain/aws129
- Espay, A. J., Aybek, S., Carson, A., et al. (2018). Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurology, 75(9), 1132–1141. https://doi.org/10.1001/jamaneurol.2018.1264
- Goldstein, L. H., Robinson, E. J., Mellers, J. D. C., et al. (2020). Cognitive behavioural therapy for adults with dissociative seizures (CODES): A pragmatic, multicentre, randomised controlled trial. The Lancet Psychiatry, 7(6), 491–505. https://doi.org/10.1016/S2215-0366(20)30128-0
- Keatley, E. S., Cairncross, M., Raman, S., Molton, I. R., Choi, E., O’Kane, K., Buchholz, A. S., LaFaver, K., & Aaron, R. V. (2026). Rehabilitation therapies for functional neurological disorder: A systematic review and meta-analysis of clinical trials. Journal of Neuropsychiatry and Clinical Neurosciences, 38(4), 318–328. https://doi.org/10.1176/appi.neuropsych.20250222
- LaFrance, W. C., Jr., Baird, G. L., Barry, J. J., et al. (2014). Multicenter pilot treatment trial for psychogenic nonepileptic seizures: A randomized clinical trial. JAMA Psychiatry, 71(9), 997–1005. https://doi.org/10.1001/jamapsychiatry.2014.817
- McLoughlin, C., McGhie-Fraser, B., Carson, A., Olde Hartman, T., & Stone, J. (2024). How stigma unfolds for patients with functional neurological disorder. Journal of Psychosomatic Research, 181, 111667. https://doi.org/10.1016/j.jpsychores.2024.111667
- Nicholson, C., Edwards, M. J., Carson, A. J., et al. (2020). Occupational therapy consensus recommendations for functional neurological disorder. Journal of Neurology, Neurosurgery & Psychiatry, 91(10), 1037–1045. https://doi.org/10.1136/jnnp-2019-322281
- Nielsen, G., Stone, J., Matthews, A., et al. (2015). Physiotherapy for functional motor disorders: A consensus recommendation. Journal of Neurology, Neurosurgery & Psychiatry, 86(10), 1113–1119. https://doi.org/10.1136/jnnp-2014-309255
- Nielsen, G., Buszewicz, M., Stevenson, F., et al. (2017). Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery & Psychiatry, 88(6), 484–490. https://doi.org/10.1136/jnnp-2016-314408
- Nielsen, G., Stone, J., Lee, T. C., et al. (2024). Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): A pragmatic, multicentre, phase 3 randomised controlled trial. The Lancet Neurology, 23(7), 675–686. https://doi.org/10.1016/S1474-4422(24)00135-2
- Nielsen, G., Marston, L., Hunter, R. M., et al. (2025). Outcomes of specialist physiotherapy for functional motor disorder: The Physio4FMD RCT. Health Technology Assessment, 29(34), 1–28. https://doi.org/10.3310/MKAC9495
- Pritomanova, I., Cope, S. R., James, B., et al. (2026). The journey to diagnosis and care of functional neurological disorder (FND). PLOS ONE, 21(4), e0328321. https://doi.org/10.1371/journal.pone.0328321
- Thomas, S. T., Thomas, E. T., Schembri, E., Lehn, A. C., & Palmer, D. D. G. (2025). Treatment outcomes in functional neurological disorder: A systematic review and meta-analysis exploring the influence of symptom chronicity. BMJ Neurology Open, 7(2), e001150. https://doi.org/10.1136/bmjno-2025-001150
- Vassilopoulos, A., Mohammad, S., Dure, L., Kozlowska, K., & Fobian, A. D. (2022). Treatment approaches for functional neurological disorders in children. Current Treatment Options in Neurology, 24(2), 77–97. https://doi.org/10.1007/s11940-022-00708-5
- World Health Organization. (2001). International classification of functioning, disability and health (ICF). World Health Organization. https://www.who.int/standards/classifications/international-classification-of-functioning-disability-and-health